Zachary Silbersher v. Allergan, Inc., et al
| UNITED STATES OF AMERICA, EX REL. ZACHARY SILBERSHER, Relator |
| ALLERGAN, INC., ALLERGAN USA, INC., ALLERGAN SALES, LLC, FOREST LABORATORIES HOLDINGS, LTD., ADAMAS PHARMA LLC and ADAMAS PHARMACEUTICALS, INC. |
| 23-15613 |
| April 25, 2023 |
| U.S. Court of Appeals, Ninth Circuit |
| Qui Tam False Claims Act |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 31, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 MEDIATION ORDER FILED: This case is RELEASED from the Mediation Program. Counsel are requested to contact the Circuit Mediator should circumstances develop that warrant settlement discussions. [12726066] (BLS) [Entered: 05/31/2023 04:37 PM] |
| Filing 8 MEDIATION ORDER FILED: By 05/22/2023, counsel to email Circuit Mediator regarding settlement potential. Include Ninth Circuit case name and number in subject line. This communication will be kept confidential, if requested, and should not be filed with the court. The existing briefing schedule remains in effect. SEE ORDER FOR DETAILS. [12716381] (BLS) [Entered: 05/15/2023 09:10 PM] |
| Filing 7 Filed (ECF) Appellees Adamas Pharma LLC and Adamas Pharmaceuticals, Inc. Mediation Questionnaire. Date of service: 05/02/2023. [12707285] [23-15613] (Hoffman, Andrew) [Entered: 05/02/2023 02:06 PM] |
| Filing 6 The Mediation Questionnaire for this case was filed on 05/02/2023. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[12707181]. [23-15613] (AD) [Entered: 05/02/2023 12:44 PM] |
| Filing 5 Filed (ECF) Appellant Zachary Silbersher Mediation Questionnaire. Date of service: 05/02/2023. [12707128] [23-15613] (Herrera, Nicomedes) [Entered: 05/02/2023 11:49 AM] |
| Filing 4 Added Attorneys Erin E. Murphy and James Xi for Appellees Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc. and Forest Laboratories Holdings, Ltd., in case 23-15613. [12706911] (HH) [Entered: 05/02/2023 09:27 AM] |
| Filing 3 Filed (ECF) notice of appearance of James Y. Xi (706 Duke Street, Alexandria, VA 22134) for Appellees Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc. and Forest Laboratories Holdings, Ltd.. Date of service: 05/02/2023. (Party was previously proceeding with counsel.) [12706888] [23-15613] (Xi, James) [Entered: 05/02/2023 09:19 AM] |
| Filing 2 Filed (ECF) notice of appearance of Erin E. Murphy (706 Duke Street, Alexandria, VA 22134) for Appellees Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc. and Forest Laboratories Holdings, Ltd.. Date of service: 05/02/2023. (Party was previously proceeding with counsel.) [12706866] [23-15613] (Murphy, Erin) [Entered: 05/02/2023 09:13 AM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Appellant Zachary Silbersher Mediation Questionnaire due on 05/02/2023. Transcript ordered by 05/24/2023. Transcript due 06/22/2023. Appellant Zachary Silbersher opening brief due 07/31/2023. Appellees Adamas Pharma LLC, Adamas Pharmaceuticals, Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc. and Forest Laboratories Holdings, Ltd. answering brief due 08/31/2023. Appellant's optional reply brief is due 21 days after service of the answering brief. [12702835] (RT) [Entered: 04/25/2023 03:44 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
